Open Terminal →

Analyses / JPM

JPM JPMorgan Chase & Co. As of Nov 19, 2026
$324.11

Large-cap bank trading mid-range after a down day. Strong margins and low trailing P/E, offset by slow revenue growth and insider net selling by count.

Setup: Mid-range consolidation, quality value watchlist Confidence: medium Horizon: 3 to 6 months Risk: medium Category: Large Cap
🔒 Trade Plan — entry · target · stop
Entry Zone
$•••–•••
Target
$•••
Stop Loss
$•••
Risk / Reward
•.• : 1
Unlock the exact levels — free →

A free account reveals JPM's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.

The Thesis

▲ Bull Case

Trailing P/E of 13.2x and P/B of 2.4x sit at a modest multiple for a bank with a 35.9% operating margin and 29.3% net margin. EPS growth of 17.4% (TTM) and 16.8% (5Y) is strong. Dividend yield of 2.7% is covered by a 29.1% payout ratio. If the stock reclaims the prior close near 330 and the 52-week high of 366.5 comes back into view, the current discount to that range could narrow. Beta of 1.05 suggests market-like sensitivity.

▼ Bear Case

Revenue growth is slow at 3.4% (TTM) versus 7.7% (5Y), so earnings growth may rely on margins or one-off factors. Forward P/E of 15.2x sits above trailing 13.2x, which implies lower expected earnings per share; this conflicts with the positive EPS growth figure and needs reconciling. Price-to-FCF of 67x suggests weak free cash flow conversion. Insider activity shows 108 sell transactions versus 90 buys. The stock fell 1.8% on the day and sits about 51% up its 52-week range.

Valuation

FAIRLY VALUED — score 55/100

Low trailing multiples and high margins are offset by slow revenue growth, a high price-to-FCF multiple and an unreconciled forward P/E.

Technical Levels

Support · $323.71 (Day low) · $327.52 (Day open) · $279.10 (52-week low)

Resistance · $329.96 (Prior close) · $330.09 (Day high) · $366.50 (52-week high)

RSI: Not available in payload

Financial Health

Score 55/100. Payout ratio is moderate and beta is near market. Standard leverage and liquidity ratios are not in the payload, and bank balance sheets need bank-specific metrics not provided here.

Catalysts

CFO transition: Bregje de Best named next CFORecent (news dated in payload)medium
Fed rate path and political risk commentary (Fed Chair Kevin Warsh, Senate control)Ongoinghigh
Quarterly earnings report (date not in payload)Not providedhigh

Risk Flags

Forward P/E (15.2x) above trailing P/E (13.2x) conflicts with reported 17.4% EPS growth. Verify consensus estimates.
Price-to-FCF of 67x; FCF per share and FCF-to-net-income are unavailable in the payload.
Insider activity: 108 sells vs 90 buys by count; shares sold 2.45M vs bought 2.65M.
ROE, ROIC, debt-to-equity, RSI, EV/EBITDA and PEG are null in the payload and are excluded from scoring.
News timestamps appear far in the future relative to typical feeds. Verify dates before relying on sequence.
Peer and sector benchmarks are not in the payload; benchmark labels below are qualitative.

See JPM's full trade plan — free

Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.

Unlock JPM free →

Recent News

More Analyses

JPM FAQ

Is JPM a buy right now?

JPMorgan Chase & Co.'s current read is a Mid-range consolidation, quality value watchlist setup with medium confidence over a 3 to 6 months horizon. Valuation: FAIRLY VALUED. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.

Is JPM overvalued?

FAIRLY VALUED (valuation score 55/100). Low trailing multiples and high margins are offset by slow revenue growth, a high price-to-FCF multiple and an unreconciled forward P/E.

What are the risks of buying JPM?

Revenue growth is slow at 3.4% (TTM) versus 7.7% (5Y), so earnings growth may rely on margins or one-off factors. Forward P/E of 15.2x sits above trailing 13.2x, which implies lower expected earnings per share; this conflicts with the positive EPS growth figure and needs reconciling. Price-to-FCF of 67x suggests weak free cash flow conversion. Insider activity shows 108 sell transactions versus 90 buys. The stock fell 1.8% on the day and sits about 51% up its 52-week range.